-- the acceptability and efficacy of new antibilharzian drugs , praziquantel and oltipraz . with the aim of improving the cost/effectiveness ratio of these campagnes and taking into account the health requirements which exist and/or are desired by the population , the authors propose four modifications of the strategy of mass control : -- the integration of schistosoma haematobium bilharziasis control with the other regional health priorities ;
C0032911
praziquantel
C0036323
bilharziasis